New York State Common Retirement Fund
NRIX icon

New York State Common Retirement Fund’s Nurix Therapeutics NRIX Stock Holding History

New York State Common Retirement Fund’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
49,780
+18,185
+58% +$310K ﹤0.01% 1661
2026
Q1 		$490K Hold
31,595
– – ﹤0.01% 1910
2025
Q4 		$599K Buy
31,595
+10,400
+49% +$149K ﹤0.01% 1899
2025
Q3 		$196K Sell
21,195
-31,493
-60% -$327K ﹤0.01% 2306
2025
Q2 		$600K Hold
52,688
– – ﹤0.01% 1851
2025
Q1 		$626K Buy
52,688
+31,493
+149% +$527K ﹤0.01% 1822
2024
Q4 		$399K Hold
21,195
– – ﹤0.01% 2018
2024
Q3 		$476K Sell
21,195
-4,177
-16% -$94.6K ﹤0.01% 1957
2024
Q2 		$530K Buy
25,372
+9,041
+55% +$141K ﹤0.01% 2026
2024
Q1 		$240K Buy
16,331
+175
+1% +$1.88K ﹤0.01% 2353
2023
Q4 		$167K Buy
16,156
+6,025
+59% +$41.3K ﹤0.01% 2538
2023
Q3 		$79.6K Buy
10,131
+200
+2% +$1.83K ﹤0.01% 2835
2023
Q2 		$99.2K Sell
9,931
-10,006
-50% -$102K ﹤0.01% 2836
2023
Q1 		$177K Sell
19,937
-11,100
-36% -$116K ﹤0.01% 2638
2022
Q4 		$341K Buy
31,037
+12
+0% +$145 ﹤0.01% 2501
2022
Q3 		$404K Buy
31,025
+149
+0.5% +$2.36K ﹤0.01% 2446
2022
Q2 		$391K Buy
30,876
+8,255
+36% +$93.6K ﹤0.01% 2472
2022
Q1 		$317K Buy
22,621
+33
+0.1% +$586 ﹤0.01% 2617
2021
Q4 		$654K Sell
22,588
-86
-0.4% -$2.61K ﹤0.01% 2301
2021
Q3 		$679K Sell
22,674
-4,360
-16% -$135K ﹤0.01% 2299
2021
Q2 		$717K Buy
27,034
+8,794
+48% +$258K ﹤0.01% 2391
2021
Q1 		$567K Buy
18,240
+7,800
+75% +$295K ﹤0.01% 2393
2020
Q4 		$343K Buy
10,440
+4,100
+65% +$136K ﹤0.01% 2526
2020
Q3 		$221K Buy
+6,340
New +$160K ﹤0.01% 2603

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

New York State Common Retirement Fund's NRIX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Nurix Therapeutics (NRIX) stake by 58% in Q2 2026, buying an estimated $310K and bringing the position to 49,780 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

New York State Common Retirement Fund first reported a position in NRIX in Q3 2020 and has held it in 24 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • New York State Common Retirement Fund held 49,780 shares of Nurix Therapeutics worth $1.21M as of Q2 2026.
  • New York State Common Retirement Fund bought 18,185 Nurix Therapeutics shares in Q2 2026, an estimated $310K.
  • Nurix Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1661 holding.
  • New York State Common Retirement Fund first reported a position in Nurix Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.